Elon Musk: THIS will be bigger than Tesla
Sponsored
Elon Musk's new robots have an AI brain. They could eventually cook you a pot roast… Mow your lawn… He's even hinted at creating a “romantic companion” version…… He says his new robots could soon be bigger than Tesla. That's just the start. In fact, I now believe AI technology… Will be the first $100 TRILLION industry. There could be trillions available to those who get in early… If you missed out on making money on crypto… Your second chance could be starting now. Today, for the first time… I'm showing good Americans exactly what to do… Go here now to see my plan… For investing in AI during this brief “wealth window”. P.S. To show you I'm serious about helping you get in on this opportunity, I'm giving away one of my top 5 AI 2.0 stock picks – free. See my top 5 pick here now.
There’s been a major shift in the markets, and it’s gone unnoticed by most investors.
A fascinating type of trade is gaining steam right now, and I believe the beginning of this trend will eventually be more significant than the day the Chicago Board Options Exchange (CBOE) was created.
You see, back in 1973, an original options pricing model was officially unleashed to the public. This model became the single greatest wealth creation tool in the history of modern finance, and it even went on to win a Nobel Prize.
At around the same time the model was released, the first stock option was bought at the CBOE, on April 26, 1973: Xerox July $160 calls.
Since then, traders have made trillions – not billions, trillions – of dollars using options.
And now, thanks to several technological advancements, we have access to a new type of trade that could make that day in April 1973 seem like the Stone Age in comparison.
This new asset class is called zero-day options, also known as 0DTE (zero days to expiration) options.
Over the past two years, 0DTEs have exploded in popularity, and one of the main reasons is their immense profit potential. 0DTEs essentially have unlimited upside. You could see gains of 100%, 500%, even 1,000% on a single trade… in a single day.
0DTE contracts expire at the end of the current trading day, which means you could see those major gains in hours or even minutes.
Another benefit is that these option contracts carry super-low premiums since they expire the same day. This is great for investors with smaller trading accounts. You can make many 0DTE trades for $100 or less.
Plus, these options are currently available on only heavily traded tickers, as they aren’t viable without significant trading volume. As a result, 0DTEs bring you into super-liquid situations where spreads are thin and there’s enough volume that you can easily get in AND out.
As you’ll see below, the data doesn’t lie: More and more retail traders are being drawn to 0DTEs. In fact, trading volume on 0DTEs just hit an all-time high.
Now, 0DTEs aren’t perfect. No trading strategy is.
For one, they move up and down quickly, so you have to be ready to get in and out when the moves occur.
Second, because they move so fast, you can see big gains or losses instantly in some cases. The best way to manage your risk is to use proper position sizing, preset sell-stop orders and specific profit targets.
To put yourself in position to profit off a new asset class like 0DTEs, it’s essential that you properly educate yourself and trade strategically.
AI medical stock landing MASSIVE contracts
Sponsored
Few people know its name, but Intuitive Surgical was one of the five best stocks of the last 20 years.
It went up as much as 18,000% in two decades.
Why?
Because it used new technology – surgical robotics – to drive sales sky high.
Now… another company is following its path.
The company is tiny today – just $500 million – but it is in position to grow dramatically.
In short, it is the inventor of the world's first AI-designed drug to enter clinical trials.
And big pharma is lining up to use its patent-protected technology.
- Merck is collaborating with them on three projects that could generate up to $674 million in revenue.
- French pharma giant Sanofi agreed to pay the company up to $5.2 billion to develop 15 new drugs.
- Bristol Meyers Squibb signed a $1.2 billion partnership with the company.
You can see… each one of these projects is worth more than the entire market cap of this new AI stock!
In short, the upside is MASSIVE.
Which is why I wanted to send you this video.
It comes from one of the great stock pickers of all-time – a man who actually recommended Intuitive Surgical in real time back in 2004.
In fact, he called 4 of the top 6 performing stocks from 2000 to 2020.
And he says this new company is the #1 AI Stock Under $10.
